Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Health Management Associates (NYSE: HMA ) , an acute-care hospital and health care facility operator in the U.S., jumped as much as 11% after a hedge fund noted interest in raising its stake in the company and following two analyst upgrades.
So what: The bump primarily comes from a filing with the Securities and Exchange Commission in which Glenview Capital -- currently Health Management's largest shareholders with 37.8 million shares ��urged the company to abandon or amend its poison pill to allow it to acquire up to 25% of all outstanding shares (currently the cap is 15%). Glenview also noted in that filing that it'd consider replacing part or all of Health Management's board of directors. In addition to this ongoing drama, research firms CRT Capital and WallachBeth upgraded Health Management to "hold" and "buy," respectively, from previous ratings of "sell" and "hold."
Top Net Payout Yield Stocks To Own Right Now: Alnylam Pharmaceuticals Inc.(ALNY)
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). Its core product programs under clinical or pre-clinical development include ALN-TTR, a Phase I clinical trial program for the treatment of transthyretin-mediated amyloidosis; ALN-APC, a Phase I clinical trial program for the treatment of hemophilia; ALN-PCS for the treatment of severe hypercholesterolemia; ALN-HPN, a pre-clinical development for the treatment of refractory anemia; and ALN-TMP, a pre-clinical development for the treatment of hemoglobinopathies, including beta-thalassemia and sickle cell anemia. The company?s partner-based programs comprise ALN-RSV01, a Phase II clinical trial program for the treatment of respiratory syncytial virus infection; ALN-VSP, a Phase I clinical trial completed program for the treatment of liver cancers; and ALN-HTT, a pre-clinical development for the treatment of Huntington?s disease. It has strategic alliances with Novartis Pharma AG; F. Hoffmann-La Roche Ltd; Takeda Pharmaceutical Company Limited; Isis Pharmaceuticals, Inc.; Medtronic Inc.; Kyowa Hakko Kirin Co., Ltd.; and Cubist Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Advisors' Opinion:- [By Jake L'Ecuyer]
Equities Trading UP
Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY) got a boost, shooting up 53.25 percent to $101.47 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.
Top 5 Sliver Stocks To Buy Right Now: Teucrium Wheat Fund (WEAT)
Teucrium Wheat Fund (the Fund) is a commodity pool. The Fund is a series of the Teucrium Commodity Trust (Trust). The Fund provides investors unleveraged direct exposure to wheat without the need for a futures account. The investment objective of the Fund is to have the daily changes in percentage terms of a weighted average of the closing settlement prices for three futures contracts for wheat (Wheat Futures Contracts) that are traded on the Chicago Board of Trade (CBOT), which includes the second-to-expire CBOT Wheat Futures Contract, weighted 35%; the third-to-expire CBOT Wheat Futures Contract, weighted 30%, and the CBOT Wheat Futures Contract, weighted 35%. The Fund is managed by Teucrium Trading, LLC. Advisors' Opinion:- [By Paul Ausick]
The Teucrium Wheat Fund (NYSEMKT: WEAT) closed down 2.43% on Friday to finish the week at $16.47. For the week the fund was up 0.8%. The 52-week range is $13.31 to $19.50. Like corn, the price is up more than 12% since the beginning of the year and down 10.5% over the past 12 months. This fund trades averages just 41,000 shares traded in a day, but nearly tripled that on Friday, when wheat prices fell more than 2% on the CBOT to close at $6.955 a bushel.
Top 5 Sliver Stocks To Buy Right Now: Digital Realty Trust Inc.(DLR)
Digital Realty Trust, Inc., a real estate investment trust (REIT), through its controlling interest in Digital Realty Trust, L.P., engages in the ownership, acquisition, development, redevelopment, and management of technology-related real estate. It focuses on strategically located properties containing applications and operations critical to the day-to-day operations of technology industry tenants and corporate enterprise datacenter users, including the information technology departments of Fortune 1000 companies, and financial services companies. The company?s property portfolio consists of Internet gateway properties, corporate datacenter properties, technology manufacturing properties, and regional or national offices of technology companies. As of December 31, 2008, Digital Realty?s portfolio consisted of 75 properties, including 62 located in North America and 13 located in Europe. Digital Realty Trust has elected to be treated as a REIT for federal income tax purpo ses and would not be subject to income tax, if it distributes at least 90% of its REIT taxable income to its stockholders. The company was founded in 2004 and is headquartered in San Francisco, California with additional offices in Boston, Chicago, Dallas, Los Angeles, New York, Northern Virginia, and Phoenix, as well as in Dublin, London, and Paris.
Advisors' Opinion:- [By Editor , Dividend Growth Investor]
The following three dividend growth stocks have managed to defy skeptics expectations, and prove them wrong, time and again. The companies are Digital Realty Trust (DLR), Dr Pepper Snapple (DPS) and PepsiCo (PEP).
- [By Rick Munarriz]
Friday
Things are usually quiet on Fridays, but that won't stop Digital Realty Trust (NYSE: DLR ) from reporting.The REIT specializing in data center properties came under attack two months ago, when Highfields Capital Management argued that Digital Realty's model and its dividends aren't sustainable. The REIT fought back, but the shares continue to trade for less than they did at the time of the bearish comments from the hedge fund.
- [By Adam Aloisi]
Trading 30% lower than it did around a year ago and with a short float of around 20%, data services provider Digital Realty (DLR) has developed into the REIT industry's most controversial stock. Short interest has more than doubled over the past six months, aided largely by a highly publicized bearish position taken by Highfield Capital's Jonathan Jacobsen. Though the stock trades at a fairly low multiple based on current operating expectations, investors appear about as motivated to buy a piece of DLR as they would a beach house with a hurricane approaching.
Top 5 Sliver Stocks To Buy Right Now: Petroquest Energy Inc(PQ)
PetroQuest Energy, Inc. operates as an independent oil and gas company. It engages in the acquisition, exploration, development, and operation of oil and gas properties in Oklahoma, Arkansas, and Texas, as well as onshore and in the shallow waters offshore the Gulf Coast Basin. As of December 31, 2009, the company had estimated proved reserves of 1,931 thousand barrels of oil and 167,361 million cubic feet equivalent of natural gas. It owned working interests in 9 net producing oil wells and 277 net producing gas wells. PetroQuest Energy was founded in 1983 and is headquartered in Lafayette, Louisiana.
Advisors' Opinion:- [By Jon C. Ogg]
PetroQuest Energy Inc. (NYSE: PQ) was downgraded to Neutral from Overweight at J.P. Morgan.
Rubicon Technology Inc. (NASDAQ: RBCN) was downgraded to Underperform from Perform at Oppenheimer.
No comments:
Post a Comment